ENvue Medical, Inc.: net property, plant and equipment
Net property, plant and equipment for ENvue Medical, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ENvue Medical, Inc. financial histories
What this measure means
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2014-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 119,000 | USD | 2026-04-15 | 10-K · 0001493152-26-016871 |
| At date | 2024-12-31 | 9,000 | USD | 2026-04-15 | 10-K · 0001493152-26-016871 |
| At date | 2023-12-31 | 7,000 | USD | 2025-03-31 | 10-K · 0001641172-25-001613 |
| At date | 2022-12-31 | 7,000 | USD | 2024-04-08 | 10-K · 0001493152-24-013966 |
| At date | 2021-12-31 | 5,000 | USD | 2023-04-17 | 10-K · 0001493152-23-012570 |
| At date | 2020-12-31 | 4,000 | USD | 2022-04-15 | 10-K · 0001493152-22-009985 |
| At date | 2019-12-31 | 4,000 | USD | 2021-04-15 | 10-K · 0001493152-21-008951 |
| At date | 2018-12-31 | 8,000 | USD | 2020-05-20 | 10-K · 0001493152-20-009519 |
| At date | 2017-12-31 | 5,000 | USD | 2019-05-13 | 10-K · 0001615774-19-007616 |
| At date | 2016-12-31 | 11,000 | USD | 2018-03-29 | 10-K · 0001615774-18-002203 |
| At date | 2015-12-31 | 10,000 | USD | 2017-07-26 | 10-K/A · 0001615774-17-003832 |
| At date | 2014-12-31 | 18,000 | USD | 2016-03-30 | 10-K · 0001144204-16-091141 |
Related financial histories
- ENvue Medical, Inc.: total assets
- ENvue Medical, Inc.: total liabilities
- ENvue Medical, Inc.: stockholders equity
- ENvue Medical, Inc.: cash and cash equivalents
- ENvue Medical, Inc.: net income or loss
- ENvue Medical, Inc.: operating cash flow
- ENvue Medical, Inc.: capital expenditure payments
- ENvue Medical, Inc.: revenue
- ENvue Medical, Inc.: contract revenue excluding tax
- ENvue Medical, Inc.: financing cash flow
- ENvue Medical, Inc.: investing cash flow
- ENvue Medical, Inc.: retained earnings or deficit
- ENvue Medical, Inc.: basic weighted-average shares
- ENvue Medical, Inc.: diluted weighted-average shares
- ENvue Medical, Inc.: basic earnings per share
- ENvue Medical, Inc.: diluted earnings per share
- ENvue Medical, Inc.: income tax expense or benefit
- ENvue Medical, Inc.: share-based compensation expense
- ENvue Medical, Inc.: operating income or loss
- ENvue Medical, Inc.: current assets
- ENvue Medical, Inc.: interest expense
- ENvue Medical, Inc.: current liabilities
- ENvue Medical, Inc.: current accounts payable
- ENvue Medical, Inc.: net current accounts receivable
- ENvue Medical, Inc.: operating expenses
- ENvue Medical, Inc.: net inventory
- ENvue Medical, Inc.: gross profit
- ENvue Medical, Inc.: cost of revenue
- ENvue Medical, Inc.: research and development expense
Inspect the source
- Entity
- ENvue Medical, Inc. / CIK 0001326706
- Captured
- 2026-09-20T07:52:45.150Z
- SEC response SHA-256
65e67c6b620de6561a1306549430000ba4a1ea03bfa7cf2b9d62752040f6daf8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001326706.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))